Pfizer (PFE) — Entry Risk Score
Stock · re-scored every trading day · data as of 2026-11-12
The entry score measures one thing: how far Pfizer's price sits from a defensible technical level, on a 30–98 scale. High scores (79+) mean the price has pulled back into a zone where risk can be defined; low scores mean the price is extended above its own trend — not that the stock is bad, but that chasing it here carries undefined risk. The full formula is public on our methodology page.
On 2026-11-12, Pfizer's price sits 1.37 ATR below its 20-day average ($29.83); it trades above its 200-day average ($26.97); its 14-day RSI is 49; it has moved -2.54% over 20 sessions; our regime filter classifies it as no confirmed trend.
Is Pfizer (PFE) a buy right now?
Pfizer scores 93/98 (Strong Buy) as of 2026-11-12; it is 6.4% below its 52-week high of $30.79; it is above its 200-day average; it moved -1.91% over the last 5 sessions. A high score means our model rates today's price as a favorable, defined-risk entry, based on where it sits versus its 20-day average after adjusting for trend and volatility. It is not a prediction that the price will rise. Not investment advice.
Score history
Every point is a recorded daily snapshot, committed publicly the evening it was scored — history can't be rewritten after the fact.
| Date | Score | Δ | Close |
|---|---|---|---|
| 2026-11-12 | 93 | +0 | $28.83 |
| 2026-11-06 | 93 | +9 | $29.39 |
| 2026-11-05 | 84 | +16 | $29.88 |
| 2026-11-04 | 68 | -12 | $30.79 |
| 2026-11-03 | 80 | +19 | $30.00 |
| 2026-11-02 | 61 | -10 | $30.67 |
| 2026-10-29 | 71 | -9 | $29.95 |
| 2026-10-28 | 80 | +9 | $29.45 |
| 2026-10-27 | 71 | +1 | $29.80 |
| 2026-10-26 | 70 | +8 | $29.79 |
| 2026-10-23 | 62 | +10 | $30.03 |
| 2026-10-22 | 52 | -12 | $30.42 |
Congress trades in PFE
STOCK Act disclosures by members of Congress, cross-referenced from our Smart Money tracker.
| Traded | Politician | Type | Amount | Return since |
|---|---|---|---|---|
| 2026-09-04 | Rohit Khanna (D) | SALE | $1,001 - $15,000 | +3.3% |
Related stocks
See today's full rankings + entry plan for PFE →Get the Sunday Brief
One email a week, before the open: what the board did, which calls worked, which didn't, and what changed. Free. No spam, unsubscribe anytime.